Schedule 13G ownership disclosure
Cytek Biosciences Inc
Common Stock · CUSIP: 23285D109
Event date: 2025-06-30
- Filing-level shares
- 16,531,858.00
- Percent of class
- 13.1%
- BlackRock, Inc.
Shares: 16,531,858.00 · Class: 13.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002052113-25-003345
- Form type
- SCHEDULE 13G/A
- Filer
- BlackRock, Inc.
- CIK
- CIK 2012383
- Filed
- Jul 18, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership